Diagnostic value of thromboelastogram and thrombus molecular markers in early detection of deep vein thrombosis in patients with lower extremity fracture Authors: E. Jianfei, Mao Zheng, Wei Wei, Shaoping He, Chengliang Yuan, Zongyao Chen Published: 2024 ABSTRACT BackgroundDeep vein thrombosis (DVT) is an obstructive disease with a hindering venous reflux mechanism. The aim of this study was to identify independent risk factors for deep vein thrombosis (DVT) in patients with traumatic lower extremity fractures and assess the diagnostic value of thromboelastogram (TEG) and thrombus molecular markers.MethodsReviewed patients with lower extremity fractures were admitted from October 2022 to September 2023. DVT was screened using color Doppler ultrasonography postoperation. Patients were categorized into two groups: those with DVT (n = 61) and those without (n = 191). Logistic regression was utilized to analyze DVT risk factors in these patients, and the diagnostic effectiveness of each marker was determined using the receiver operating characteristic curve (ROC curve).ResultsSignificant differences were found in the incidence of hip (44.8%), and tibia (16.4%) fractures in the DVT groups (P < 0.001). Elevated levels of tPAIC, PIC, sTM, TAT, APTT, and TEG parameters (angle, MA, and CI) were observed in the DVT group (P < 0.05). Multivariate logistic regression revealed that PIC, sTM, TAT, angle, MA, CI, Caprini score, and hip fracture were significant risk factors for DVT.ConclusionsPatients with hip fractures showed a higher incidence of perioperative DVT. Factors such as PIC, sTM, TAT, angle, MA, CI, Caprini score, and hip fracture significantly contributed to the risk of DVT in traumatic lower limb fractures. Both thromboelastogram and thrombus molecular markers demonstrated strong diagnostic capabilities in the early detection of DVT, with comparable diagnostic efficiency. Introduction Deep vein thrombosis (DVT) is defined as an obstructive disease; its formation mechanism is that abnormal blood clots form in the deep vein vessels, which further block the blood vessels of lower limbs and hinder venous reflux [1]. The three key elements in the formation of DVT include a hypercoagulable state, intimal injury, and blood flow stasis [2]. DVT ranks among the most severe postoperative complications in orthopedic trauma patients, with the veins of the lower limb being most commonly affected. Lower limb DVT is the primary source of pulmonary thromboembolism, which is the leading cause of perioperative death among patients with traumatic lower limb fractures [3]. Early-stage DVT often lacks clear manifestations, and its symptoms can be somewhat hidden. Studies indicate that the incidence of DVT among patients with traumatic fractures in China ranges between 6.4% and 12.4%, with the highest occurrences noted in perihip and femoral shaft fractures [4]. Additionally, reported mortality rates from DVT are alarmingly high, ranging from 5.0% to 23.0%, with only 7.0% of these cases diagnosed before death [5]. Thus, early prediction and risk assessment of DVT are crucial. The principle of TEG involves simulating the human venous environment to dynamically and real-time capture the coagulation process through a receptor-driven curve. TEG provides a direct reflection of the dynamic evolution of blood coagulation, including the speed of clot formation, the firmness of the clots, and the activity of the fibrinolytic system. This information is used to assess the clinical risks of thrombosis or bleeding, thereby guiding the individualized clinical use of anticoagulant and fibrinolytic therapies, and effectively predicting the risk of DVT [6, 7]. Recent studies have demonstrated that TEG can timely and accurately monitor changes in blood coagulation in patients with traumatic lower limb fractures, which aids in guiding clinical treatment [8–10]. Thromboelastograms and thrombus molecular markers are significant in predicting the formation of DVT, offering greater sensitivity than conventional coagulation tests and providing enhanced insight into evaluating the coagulation state of patients with DVT [11–13]. However, comparisons of their clinical application effectiveness are scarce. This study aims to assess the diagnostic value of TEG and thrombus molecular markers in patients with traumatic lower limb fractures presenting with DVT. The Caprini risk assessment model is a widely used clinical tool for predicting DVT, categorizing DVT risk into various levels. As risk stratification increases, so does the associated risk of DVT [14]. The research on DVT risk assessment scales is well developed internationally, but studies in this area are currently limited within our country, where foreign scales are often directly applied for DVT risk assessment. This article also used the Caprini risk assessment model to determine independent risk factors for DVT in patients with traumatic lower limb fractures. Materials and methods Participants This research retrospectively analyzed the data of patients hospitalized with lower limb fractures between October 2022 and September 2023 in People’s Hospital of Deyang City. Eligibility for inclusion required patients to be adults over 18 years of age, hospitalized for a minimum of five consecutive days, and presenting with traumatic lower limb fractures including combined tibia and femoral fractures, hip fractures, femur fractures, or tibia fractures alone. Exclusion criteria included patients with severe hepatic or renal insufficiency, coagulation disorders, recent history of procoagulant or anticoagulant medication usage, severe infections, cancer, or pregnancy. Color Doppler ultrasound was used to assess DVT in the lower extremity veins within postoperative 1–2 days. The clinical data and imaging findings for a total of 252 eligible patients were collected for the research, categorizing the subjects into DVT and non-DVT groups. For the study, a comprehensive collection of clinical data and imaging results was conducted on a total of 252 eligible patients, subsequently classifying them into two distinct groups: those with Deep Vein Thrombosis (DVT) and those without DVT. Baseline demographics [comprising age, gender, nation, marital status, and body mass index (BMI)] and sample size power analyses were performed on the included patients. Research methods Detection method Blood samples were collected from fasting patients 1–2 days postoperatively into tubes containing 3.2% citrate anticoagulant, with each tube holding 2.7 ml and a total of two tubes used per patient. These were gently inverted to mix the contents. One tube of citrate anticoagulated whole blood was then centrifuged at 2000 rpm for 15 min at room temperature. The supernatant non-platelet plasma was combined, aliquoted uniformly, and stored at − 80 °C in the freezer. Prothrombin time (PT), activated partial thromboplastin time (APTT), antithrombin III (ATIII), and thrombin time (TT) were measured using a Sysmex CS5100 automatic coagulation analyzer. Levels of thrombin–antithrombin complex (TAT), plasmin–α2-plasmin inhibitor complex (PIC), soluble thrombomodulin (sTM), and tissue plasminogen activator–plasminogen activator inhibitor complex (tPAI) were assessed with a Sysmex HISCL5000 automatic immune analyzer. TEG was performed using a MEDCAPTAIN Haema T4 instrument, focusing on key parameters such as reaction time (R), kinetics time (K), the rate of clot formation (angle), maximum amplitude (MA), and coagulation index (CI) [15]. Research tools Caprini risk assessment scale was used [16], incorporating 40 risk factors including patient age, BMI, medical history, type of fracture, and laboratory test results. Risk factors were scored on a scale ranging from 1 to 5. Statistical analysis Sample size power analysis was performed using MedSci Sample Size tools [17], and data analyses were performed using SPSS statistical software (version 26.0; SPSS Inc.). Counting data were expressed as percentages, and the Chi-squared test was utilized for categorical variables [18]. For continuous variables, differences between groups were analyzed using a Student’s t test or Mann–Whitney U test, depending on the normality of the data. Multivariate logistic regression analysis was conducted to calculate the risk factors of DVT in traumatic lower limb fractures. The diagnostic efficacy of each index was evaluated by the receiver operating characteristic curve (ROC curve), and the area under the curve (AUC), sensitivity, specificity, and cutoff values were calculated. An AUC of ≥ 0.9 indicated a higher predictive value, 0.7 ≤ AUC < 0.9 indicated a moderate predictive value, and an AUC < 0.7 indicated a low predictive value. A two-tailed P < 0.05 was considered statistically significant. Results Comparison of clinical data between the DVT group and non-DVT group Among the 252 eligible patients, 24.21% (61/252) of the patients (mean age: 63.9±16.6 years; 34.43% male; 100.0% Han nationality) were included in the DVT group, and 75.79% (191/252) of the patients (mean age: 67.0±14.8 years; 37.17% male; 100.0% Han nationality) in the non-DVT group. Information related to baseline demographics of the included patients is included in Table 1. The power analysis was performed using the MedSci Sample Size tools, and the parameters were set to include the level of significance (α = 0.05), the desired power level (power = 1−β = 0.2), the prevalence of this exposure in the population of 15%, and the risk factor correlation level of 0.2. For the study, a comprehensive collection of clinical data and imaging results was conducted on a total of 252 eligible patients, subsequently classifying them into two distinct groups: those with Deep Vein Thrombosis (DVT) and those without DVT. Comparison of clinical data between the DVT group and non-DVT group showed that 61 out of 252 patients with traumatic lower extremity fractures developed DVT, representing 24.2% of the total, while 191 cases did not develop DVT, accounting for 75.8%. There was no significant difference in age and sex between the two groups (P > 0.05). When comparing the ratios of different fracture sites in the DVT group, the incidences of hip fracture, femoral fracture, and tibial fracture were 44.2%, 32.8%, and 16.4%, respectively, and the differences were statistically significant (P < 0.001). The Caprini scores in the DVT group were significantly higher than those in the non-DVT group (P < 0.05). Please refer to Table 1.Table 1Comparison of clinical data between the DVT group and non-DVT group [n(%)]VariableNon-DVT group (n = 191)DVT group (n = 61)χ2/tP valueAge (years)67.0 ± 14.863.9 ± 16.61.4070.188Gender0.1500.698 Male71(37.2%)21(34.4%) Female120(62.8%)40(65.6%)Fracture site50.5960.000 Fracture of tibia83(43.5%)10(16.4%)A Hip fracture14(7.3%)27(44.2%)B Fracture of the femur87(45.5%)20(32.8%)A Femur combined with tibial fracture7(3.7%)4(6.6%)C Caprini9.30 ± 2.5211.69 ± 3.403.1400.002Using the contingency table chi-square test, there was no significant difference (P>0.05) between the "Fracture of Tibia" group and the "Fracture of the Femur" group (labeled as A), but there was a significant difference (P<0.05) between the "Hip Fracture" group and the "Femur Combined with Tibial Fracture" group Table 1Comparison of clinical data between the DVT group and non-DVT group [n(%)]VariableNon-DVT group (n = 191)DVT group (n = 61)χ2/tP valueAge (years)67.0 ± 14.863.9 ± 16.61.4070.188Gender0.1500.698 Male71(37.2%)21(34.4%) Female120(62.8%)40(65.6%)Fracture site50.5960.000 Fracture of tibia83(43.5%)10(16.4%)A Hip fracture14(7.3%)27(44.2%)B Fracture of the femur87(45.5%)20(32.8%)A Femur combined with tibial fracture7(3.7%)4(6.6%)C Caprini9.30 ± 2.5211.69 ± 3.403.1400.002Using the contingency table chi-square test, there was no significant difference (P>0.05) between the "Fracture of Tibia" group and the "Fracture of the Femur" group (labeled as A), but there was a significant difference (P<0.05) between the "Hip Fracture" group and the "Femur Combined with Tibial Fracture" group Comparison of clinical data between the DVT group and non-DVT group [n(%)] Using the contingency table chi-square test, there was no significant difference (P>0.05) between the "Fracture of Tibia" group and the "Fracture of the Femur" group (labeled as A), but there was a significant difference (P<0.05) between the "Hip Fracture" group and the "Femur Combined with Tibial Fracture" group Comparison of thrombus molecular markers and thromboelastogram parameters between the DVT group and non-DVT group The levels of thrombus molecular markers and thromboelastogram parameters in the DVT group were significantly higher than those in the non-DVT group. The levels of APTT, tPAIC, PIC, sTM, and TAT in the DVT group were significantly higher than in the non-DVT group (P < 0.05). There was no significant difference in the AT III, PT, and TT levels between the DVT and non-DVT groups (P > 0.05). The levels of angle, MA, and CI in the DVT group were significantly higher than those in the non-DVT group (P < 0.05), but there was no significant difference in the R value and K value between the two groups (P > 0.05). Please see Table 2.Table 2Comparison of thrombus molecular markers and thromboelastogram parameters between the DVT group and non-DVT group [M(P25,P75)]VariableNon-DVT group(n = 191)DVT group(n = 61)UP valuePT (s)12.6(11.5,13.3)11.7(11.0,13.2)− 1.4180.156APTT (s)28.9(26.9,30.6)32.6(27.6,47.4)− 4.0640.000AT III (%)94.9(87.3,101.8)91.6(86.7,101.9)− 0.8580.391TT (s)19.3(18.1,20.8)19.3(18.6,21.7)− 0.6760.499tPAIC (ng/mL)7.4(5.6,9.6)31.8(6.9,44.0)− 5.7010.000PIC (ug/mL)0.74 (0.56,1.18)1.64(0.92,8.78)− 7.3840.000sTM (TU/mL)8.2(6.4,12.2)30.9(7.8,138.5)− 5.4030.000TAT (ng/mL)1.5(0.7,3.6)8.6(1.9,39.5)− 5.9260.000R (min)5.6(4.8,6.5)5.8(5.2,6.5)− 1.2530.210K (min)1.0(0.9,1.2)1.1(0.9,1.3)− 1.0880.277Angle (°)63.8(61.9,67.6)72.8(71.4,74.5)− 9.0100.000MA (mm)63.6(60.6,66.1)72.5(71.4,74.5)− 10.5560.000CI0.6(0.4,1.1)2.5(1.6,3.1)− 10.6440.000 Table 2Comparison of thrombus molecular markers and thromboelastogram parameters between the DVT group and non-DVT group [M(P25,P75)]VariableNon-DVT group(n = 191)DVT group(n = 61)UP valuePT (s)12.6(11.5,13.3)11.7(11.0,13.2)− 1.4180.156APTT (s)28.9(26.9,30.6)32.6(27.6,47.4)− 4.0640.000AT III (%)94.9(87.3,101.8)91.6(86.7,101.9)− 0.8580.391TT (s)19.3(18.1,20.8)19.3(18.6,21.7)− 0.6760.499tPAIC (ng/mL)7.4(5.6,9.6)31.8(6.9,44.0)− 5.7010.000PIC (ug/mL)0.74 (0.56,1.18)1.64(0.92,8.78)− 7.3840.000sTM (TU/mL)8.2(6.4,12.2)30.9(7.8,138.5)− 5.4030.000TAT (ng/mL)1.5(0.7,3.6)8.6(1.9,39.5)− 5.9260.000R (min)5.6(4.8,6.5)5.8(5.2,6.5)− 1.2530.210K (min)1.0(0.9,1.2)1.1(0.9,1.3)− 1.0880.277Angle (°)63.8(61.9,67.6)72.8(71.4,74.5)− 9.0100.000MA (mm)63.6(60.6,66.1)72.5(71.4,74.5)− 10.5560.000CI0.6(0.4,1.1)2.5(1.6,3.1)− 10.6440.000 Comparison of thrombus molecular markers and thromboelastogram parameters between the DVT group and non-DVT group [M(P25,P75)] Binary logistic regression analysis of DVT-influencing factors of traumatic lower limb fracture Binary logistic regression analysis was conducted on the influencing factors of DVT in traumatic lower limb fractures, taking the occurrence of DVT as the dependent variable and the indices showing statistical differences between groups as covariates. The data revealed that PIC, sTM, TAT, angle, MA, CI, Caprini score, and hip fracture were risk factors for DVT in traumatic lower limb fractures. Please refer to Table 3. In addition, Cox and Snell R-square and Nagelkerke R-square were analyzed to quantitatively evaluate the goodness-of-fit effect [19]. The Cox and Snell R-square based on logistic regression analysis was 0.543 and the Negolko R-square 0.811. The Cox and Snell R-squared based on logistic regression analysis was 0.543, and the Nagelkerke R-squared was 0.811.Table 3Logistic regression analysis of influencing factors of DVT formation in the traumatic lower limb fracture variableBStandard errorWaldOR95%CIP valueHip fracture− 1.5920.6436.1390.2030.058–0.7170.013Caprini− 0.1600.0578.0640.8520.762–4.0710.005APTT (s)− 0.1930.1721.2660.8240.588–1.1540.824tPAIC (ng/mL)0.1330.1360.9641.1430.876–1.4910.326PIC (ug/mL)4.9032.4893.8801.1531.091–1.2190.049sTM (TU/mL)0.3440.1614.5721.4111.029–1.9340.032TAT (ng/mL)1.0570.5313.9612.8971.016–8.1550.047Angle (°)0.3610.06728.8121.4351.258–1.6370.000MA (mm)0.3010.05827.3421.3511.207–1.5130.000CI1.4020.29722.2154.0612.268–7.2740.000 Table 3Logistic regression analysis of influencing factors of DVT formation in the traumatic lower limb fracture variableBStandard errorWaldOR95%CIP valueHip fracture− 1.5920.6436.1390.2030.058–0.7170.013Caprini− 0.1600.0578.0640.8520.762–4.0710.005APTT (s)− 0.1930.1721.2660.8240.588–1.1540.824tPAIC (ng/mL)0.1330.1360.9641.1430.876–1.4910.326PIC (ug/mL)4.9032.4893.8801.1531.091–1.2190.049sTM (TU/mL)0.3440.1614.5721.4111.029–1.9340.032TAT (ng/mL)1.0570.5313.9612.8971.016–8.1550.047Angle (°)0.3610.06728.8121.4351.258–1.6370.000MA (mm)0.3010.05827.3421.3511.207–1.5130.000CI1.4020.29722.2154.0612.268–7.2740.000 Logistic regression analysis of influencing factors of DVT formation in the traumatic lower limb fracture variable DVT efficacy analysis of thrombus molecular markers and thromboelastogram in predicting the occurrence of traumatic lower limb fracture The efficacy analysis of traditional coagulation tests, thrombus molecular markers, and thromboelastogram for predicting DVT in traumatic lower limb fractures was conducted using ROC curve analysis. The results indicated that the AUC values for PT and APTT of conventional coagulation tests were 0.440 and 0.673, respectively. PIC, sTM, TAT, angle, MA, and CI demonstrated high diagnostic value, with AUC values of 0.834, 0.808, 0.850, 0.883, 0.897, and 0.879, respectively. The combined diagnostic approach using angle, MA, and CI for DVT had an AUC of 0.976, with sensitivity and specificity rates of 93.4% and 95.3%, respectively. Additionally, the combination of PIC, sTM, and TAT for DVT diagnosis yielded an AUC of 0.973, with sensitivity and specificity of 90.2% and 96.3%, respectively. Please refer to Table 4 and Fig. 1 for detailed data.Table 4DVT efficacy analysis of both single and combined indices in the diagnosis of traumatic lower limb fracture indexSensitivity (%)Specificity (%)AUC95%CICutoff valuePT8.297.40.4400.355–0.52432.500APTT49.296.90.6730.578–0.76833.400Caprini67.272.30.6160.538 to − 0.69410.500PIC (ug/mL)78.784.30.8340.770–0.8970.845sTM (TU/mL)63.997.40.8080.731–0.88612.900TAT (ng/mL)63.995.30.8500.787–0.9133.850Angle (°)93.480.10.8830.836–0.93168.400MA (mm)91.882.70.8970.842–0.95268.150CI85.284.30.8790.837–0.9211.400Angle + MA + CI93.495.30.9760.956–0.996/PIC + sTM + TAT90.296.30.9730.949–0.996/Fig. 1PT, APTT, PIC, sTM, TAT, angle, MA, CI, and combined indicators to predict the ROC curve of DVT Table 4DVT efficacy analysis of both single and combined indices in the diagnosis of traumatic lower limb fracture indexSensitivity (%)Specificity (%)AUC95%CICutoff valuePT8.297.40.4400.355–0.52432.500APTT49.296.90.6730.578–0.76833.400Caprini67.272.30.6160.538 to − 0.69410.500PIC (ug/mL)78.784.30.8340.770–0.8970.845sTM (TU/mL)63.997.40.8080.731–0.88612.900TAT (ng/mL)63.995.30.8500.787–0.9133.850Angle (°)93.480.10.8830.836–0.93168.400MA (mm)91.882.70.8970.842–0.95268.150CI85.284.30.8790.837–0.9211.400Angle + MA + CI93.495.30.9760.956–0.996/PIC + sTM + TAT90.296.30.9730.949–0.996/ DVT efficacy analysis of both single and combined indices in the diagnosis of traumatic lower limb fracture index PT, APTT, PIC, sTM, TAT, angle, MA, CI, and combined indicators to predict the ROC curve of DVT Discussion DVT is a common complication of traumatic lower limb fractures, often leading to PTE and serving as a significant factor in perioperative mortality among fracture patients. In this study, the incidence of DVT was analyzed in 252 patients with traumatic lower limb fractures, revealing an incidence rate of 24.2%. The comparison of different fracture sites within the DVT group showed that the ratios of hip fractures, femoral fractures, and tibial fractures were 44.2%, 32.8%, and 16.4%, respectively, with statistically significant differences (P < 0.001). A study by Khan et al. reported a DVT incidence of 41.4% in 186 patients with hip fractures [20]. Similarly, a study by Zhang et al. analyzed 463 patients with hip fractures and found that despite preventive measures, the incidence of DVT remained as high as 35.0% [21]. These findings indicate a higher incidence of lower limb DVT during the perioperative period in patients with hip fractures. According to the analysis of the causes, the occurrence of fractures in different locations depends on the type of injury. Hip fractures, often resulting from high-energy trauma, are typically caused by significant force and accompanied by severe surrounding tissue injury, which releases numerous inflammatory mediators. Moreover, high-energy trauma can trigger a stress response, leading to a hypercoagulable state and vascular endothelial injury. In this study, logistic regression analysis based on the ratios of different fracture sites within the DVT group identified hip fractures as a risk factor for DVT formation. Therefore, it is crucial to implement targeted DVT prevention measures for hip fracture patients in clinical practice. The findings indicated that the Caprini scores in the DVT group were significantly higher than those in the non-DVT group. Binary logistic regression analysis revealed that the Caprini score was a risk factor for DVT in patients with traumatic lower limb fractures. ROC curve analysis results demonstrated that the sensitivity of the Caprini score in predicting the risk of DVT formation in lower limb fractures was 0.770, suggesting that the Caprini score could serve as a risk screening index for DVT formation in lower limb fractures. Additionally, the optimal cutoff value predicted by the Caprini score was 10.5, indicating that patients with a Caprini score ≥ 10 faced an increased risk of DVT. Due to the relative concealment of early symptoms in some patients with traumatic lower limb fractures, low Caprini scores may not accurately predict the risk of DVT formation; however, elevated levels of plasma thrombus molecular markers often identify a high-risk population for DVT with abnormal coagulation function. During thrombosis, the vascular endothelium releases or synthesizes numerous substances, with tPAIC, PIC, sTM, and TAT being key molecular markers in the thrombotic process. Trauma to the vascular intima leads to endothelial cell damage, causing sTM to be released into the bloodstream. The level of sTM in plasma serves as an indicator of the extent of vascular endothelial damage. tPAIC, primarily secreted by vascular endothelial cells, is released more abundantly during thromboembolic events, indicating endothelial cell activity. TAT, a complex formed by the interaction between thrombin and antithrombin, reflects the production and activity of thrombin. When a thrombus forms, the fibrinolytic system is activated to facilitate thrombolysis, aiding in the diagnosis of thrombotic diseases [22]. A study by Li Wenwen et al. reported higher levels of PIC, sTM, TAT, and tPAIC in the DVT group compared to the non-DVT group, with TAT showing the highest AUC of 0.849 in ROC curve analysis [23]. It was found that the levels of PIC, sTM, TAT, and tPAIC were significantly elevated in the DVT group. Binary logistic regression analysis identified PIC, sTM, and TAT as risk factors for DVT in patients with traumatic lower limb fractures. The diagnostic capabilities of PIC, sTM, and TAT were assessed through ROC curve analysis, revealing that these markers had strong diagnostic performance with AUC values for DVT diagnosis at 0.834, 0.808, and 0.850, respectively. These findings suggest that PIC, sTM, and TAT are effective indicators for diagnosing DVT. Among them, TAT had the highest diagnostic efficiency, indicating a greater probability of DVT when TAT levels exceed 3.85 ng/ml. TAT, a complex formed by the interaction of thrombin and antithrombin following blood coagulation activation, is considered one of the earliest markers of coagulation system activation and tends to rise in the initial stages of thrombosis [24]. Therefore, the evaluation of TAT level can be used for early diagnosis of thrombotic diseases and monitoring of thrombolytic therapy. A study by Han Dongxu revealed that the TEG indices CI, MA, and angle have significant clinical relevance for the predictive diagnosis of DVT, as demonstrated through the analysis of ROC curve clinical diagnostic efficiency, with MA showing the best diagnostic efficacy with an AUC of 0.735 [15]. It was observed that the levels of angle, MA, and CI in the DVT group were significantly higher than in the non-DVT group. ROC curve efficiency analysis indicated that the area under the ROC curve for Angle, MA, and CI was 0.883, 0.897, and 0.879. The sensitivity and specificity of MA were 0.918 and 0.827, and MA can be used as a single indicator for the diagnosis of DVT. The AUC values of PT and APTT in traditional coagulation tests were only 0.440 and 0.673, respectively, indicating that TEG and thrombus molecular markers are more sensitive than traditional coagulation tests. This study also compared the effectiveness of TEG and thrombus molecular markers in predicting DVT in patients with traumatic lower limb fractures. The results highlighted that the combined diagnostic use of thromboelastogram indices angle, MA, and CI for DVT achieved an AUC of 0.976, with sensitivity and specificity at 93.4% and 95.3%, respectively. Similarly, the combined use of thrombus molecular markers PIC, sTM, and TAT in diagnosing DVT recorded an AUC of 0.973, with sensitivity and specificity at 90.2% and 96.3%, respectively. These findings indicate that the AUC, sensitivity, and specificity of multi-index detection are superior to single-index detection, although no significant difference was noted between TEG and thrombus molecular markers in diagnosing DVT in traumatic lower limb fractures. In 2022, a case reported by Pustake et al. involved a patient developing bilateral pedal edema following chikungunya fever and COVID-19 infection—conditions that may increase the risk of thrombotic complications [25]. This example demonstrates the importance of considering post-viral infections as contributors to a hypercoagulable state. Therefore, integrating thrombus molecular markers alongside thromboelastography (TEG) could enhance the detection and management of thrombosis, not only in trauma patients but also in those with underlying infectious etiologies. Conclusions This research retrospectively analyzed data from patients with lower extremity fractures in People’s Hospital of Deyang City over the past year to explore new methods for clinical diagnosis of DVT. The incidence of perioperative DVT in patients with hip fracture is notably high, and targeted deep vein thrombosis prophylaxis can be implemented for hip fracture patients in clinical practice. Risk factors for DVT in traumatic lower limb fractures include PIC, sTM, TAT, angle, MA, CI, the Caprini score, and the presence of a hip fracture. The measurement of PIC, sTM, TAT, angle, MA, and CI serves as effective indices for diagnosing DVT. Among these, MA stands out as the most valuable single index for diagnosing DVT in cases of traumatic lower limb fracture. Both TEG and thrombus molecular markers demonstrate strong diagnostic performance in the early detection of DVT associated with traumatic lower limb fractures, with no significant difference in diagnostic efficacy between the two methods. Therefore, TEG and thrombus molecular markers show strong clinical diagnostic ability in the early detection of DVT and have great potential in clinical practice.